Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody.
Roos Van Den NoortgateMaja KiselinovaCéline SysGeraldine P B M AccouGuy LaureysHans Van VlierbergheFrederik BerrevoetElke O KrepsPublished in: Case reports in infectious diseases (2023)
Toxoplasma gondii , an obligate intracellular parasitic protozoon, usually causes a mild, acute infection followed by a latent asymptomatic phase with tissue cysts or a chronic form with recurrent retinochoroiditis. However, immunocompromised patients can cause disseminated disease due to the reactivation of the latent tissue cysts or due to a primary infection. Here, we present a rare case of bilateral ocular toxoplasmosis and concurrent subacute toxoplasma encephalitis in a 70-year-old patient on anti-CD40 treatment following his liver transplant. The diagnosis was confirmed by PCR of anterior chamber fluid and brain biopsy, and no other sites of disseminated disease were detected on PET-CT. The patient has been treated with sulfamethoxazole-trimethoprim 800/160 mg with virtually complete resolution of the neurological and ocular symptoms. Iatrogenic blockade of the CD40 pathway may elicit a particular susceptibility for CNS reactivation of T. gondii .
Keyphrases
- toxoplasma gondii
- pet ct
- case report
- rare case
- monoclonal antibody
- newly diagnosed
- end stage renal disease
- respiratory failure
- liver failure
- nk cells
- prognostic factors
- drug induced
- optic nerve
- intensive care unit
- radiation therapy
- positron emission tomography
- white matter
- multiple sclerosis
- depressive symptoms
- physical activity
- resting state
- microbial community
- acute respiratory distress syndrome
- rectal cancer
- real time pcr